News

October 3, 2016

Cancer Research UK Readies Collaborative Study of New Immunotherapy Combo for Mesothelioma

News

Cancer Research UK announced the launch of a first clinical trial under the Experimental Cancer Medicine Centre (ECMC) Combinations Alliance, a collaborative effort involving the group, and, for this study, the companies MSD and Verastem. ... Read more

September 30, 2016

Pravachol May Help Prevent Radiation-Induced Side Effects, Study Finds

News

Use of the cholesterol-lowering drug Pravachol (pravastatin) before radiation therapy markedly reduces radiation-induced toxicity, researchers observed in a mouse mesothelioma model. The study, “Pravastatin Reduces Radiation-Induced Damage to Normal Tissues,” was presented ... Read more

September 29, 2016September 29, 2016

Definitive Radiation Therapy Found to Improve Survival in People with Non-Metastatic MPM

News

Patients with non-metastatic malignant pleural mesothelioma may benefit from definitive radiation therapy, according to a large retrospective study recently presented at the American Society for Radiation 2016 Annual Meeting, held ... Read more

September 28, 2016

How Mesothelioma Clinical Trials Work

News

Developing a new medical treatment for mesothelioma takes many years. The process is intended to best improve the treatment of diseases and medical conditions without harming people. Here you can read ... Read more

September 28, 2016September 28, 2016

Breath Analysis May Help Early Detection of Mesothelioma Patients, Study Finds

News

Measuring volatile organic compounds (VOCs) by breath analysis is a potent, easy-to-perform technique that can distinguish malignant pleural mesothelioma (MPM) patients from healthy people, according to a report published in the Journal of ... Read more

September 27, 2016September 27, 2016

Pleural Fluid from Mesothelioma Patients Can Induce Tumor Growth, Chemotherapy Resistance

News

Patients with malignant mesothelioma (MM) often exhibit malignant pleural effusion (MPE), a condition in which cancer causes an abnormal amount of fluid to build up in the pleural space, the ... Read more

September 26, 2016

Glucophage Doesn’t Appear to Improve Survival in Diabetics with Malignant Mesothelioma, Study Shows

News

Glucophage (metformin), an oral diabetes medicine that helps control blood sugar levels, does not improve survival among patients with type 2 diabetes and malignant pleural mesothelioma, contrary to what has ... Read more

September 26, 2016September 26, 2016

8 Things to Know About Chemo

Many mesothelioma patients will fight their cancer with chemotherapy — potent cancer cell-killing drugs that are ingested orally or delivered intravenously. When chemotherapy is prescribed, it is deemed necessary. Before starting a ... Read more

September 23, 2016

New Bromodomain Inhibitor Shows Promise in Treating Malignant Pleural Mesothelioma

News

A new bromodomain and extraterminal (BET) inhibitor, OTX015, may be a promising approach to treat malignant pleural mesothelioma (MPM), according to a recent study published in the International Journal of ... Read more

September 22, 2016September 22, 2016

Why We Need Clinical Trials for Mesothelioma

News

Clinical trials are extremely important scientific studies needed and required to assess new medical treatments, including treatments for diseases like Mesothelioma. This article explores the reasons why clinical trials are necessary, what exactly ... Read more